CASP1 and Sepsis: In 2019, a study showed that Dexmedetomidine could reduce pyroptosis and histone release of astrocytes by reducing NLRP3 and caspase-1 recruitment in vivo and vitro, which might protect comprehensively nerve cells from damage in sepsis (138).